Literature DB >> 22936280

Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.

Kenji Inoue1, Minako Shiokawa, Masato Wakakura, Goji Tomita.   

Abstract

PURPOSE: Upper eyelid sulcus deepening has recently been reported as an adverse effect of prostaglandin (PG) eye drop use. However, no data are available regarding the frequency of upper eyelid sulcus deepening caused by different types of PG eye drops. We used 5 types of PG eye drops in Japanese subjects and examined the frequency of appearance of upper eyelid sulcus deepening in these subjects. PATIENTS AND METHODS: The study included 250 patients (250 eyes) diagnosed with primary open-angle glaucoma or ocular hypertension. Five healthy patients were included as controls. One eye of each patient was treated with one of the following PG eye drops for >3 months: latanoprost, travoprost, tafluprost, bimatoprost, and isopropyl unoprostone. A single-lens reflex camera was used to photograph the open eyelids. Three ophthalmologists independently judged the appearance of the deepened upper eyelid sulcus in the photographs of the 250 patients and 5 controls by comparing the right and left eyes. A subjective self-reported symptom questionnaire was also administered.
RESULTS: Upper eyelid sulcus deepening was objectively (photograph) and subjectively (questionnaire) noted in 24.0% and 12.0%, 50.0% and 24.0%, 18.0% and 10.0%, 60.0% and 40.0%, and 8.0% and 10.0% of the patients in the latanoprost, travoprost, tafluprost, bimatoprost, and unoprostone groups, respectively. It occurred more frequently (objectively and subjectively) in the bimatoprost group than in the latanoprost, the tafluprost, and the unoprostone groups (P<0.001).
CONCLUSION: Upper eyelid sulcus deepening frequently occurred with bimatoprost usage, and this effect should be sufficiently elucidated before starting bimatoprost treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22936280     DOI: 10.1097/IJG.0b013e31824d8d7c

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  32 in total

1.  Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution.

Authors:  Rei Sakata; Shiroaki Shirato; Kazunori Miyata; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2014-01-07       Impact factor: 2.447

2.  Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.

Authors:  R Sakata; S Shirato; K Miyata; M Aihara
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

Review 3.  Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.

Authors:  Mark Sanford
Journal:  Clin Drug Investig       Date:  2014-07       Impact factor: 2.859

Review 4.  Tafluprost Ophthalmic Solution 0.0015 %: A Review in Glaucoma and Ocular Hypertension.

Authors:  Gillian M Keating
Journal:  Clin Drug Investig       Date:  2016-06       Impact factor: 2.859

Review 5.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

Review 6.  In Vivo Analysis of Prostaglandins-induced Ocular Surface and Periocular Adnexa Modifications in Patients with Glaucoma.

Authors:  Silvio DI Staso; Luca Agnifili; Sara Cecannecchia; Angela DI Gregorio; Marco Ciancaglini
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

7.  A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6).

Authors:  Kenneth W Olander; Michelle A Sato; Marc A Abrams; Gary W Jerkins; Fenghe Lu; Phillip Dinh; Noriko Odani-Kawabata; Almira Chabi; Naveed K Shams
Journal:  J Glaucoma       Date:  2021-06-01       Impact factor: 2.503

8.  Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma.

Authors:  Yang Liu; Weiming Mao
Journal:  Clin Ophthalmol       Date:  2012-12-21

9.  A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features.

Authors:  Mamta Shah; Grace Lee; Daniel R Lefebvre; Benjamin Kronberg; Stephanie Loomis; Stacey C Brauner; Angela Turalba; Douglas J Rhee; Suzanne K Freitag; Louis R Pasquale
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 10.  Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol.

Authors:  Yuan Fang; Zhihong Ling; Xinghuai Sun
Journal:  Drug Des Devel Ther       Date:  2015-05-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.